Personal information

Websites & social links

The Capital Region of Denmark profile page

Other IDs

Scopus Author ID: 16937835500
Scopus Author ID: 16937835500

Activities

Collapse all

Employment (13)

The Capital Region of Denmark: N/A, DK

Employment
Source: check_circle
Capital Region of Denmark

University of Copenhagen: Copenhagen, DK

2024 to present | Professor (Cllinical medicine)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Gentofte Hospital: Hellerup, Region Hovedstaden, DK

2022-05-08 to present | Overlæge (Brystkirurgisk afd)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Rigshospitalet: Copenhagen, DK

2014 to 2022-05-08 | Overlæge (Brystkirurgisk sektion)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Rigshospitalet: Kobenhavn, DK

2012 to 2014 | Afdelingslæge (Brystkirurgisk klinik)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Queen Ingrids Hospital: Nuuk, GL

2011 to 2011 | Vikar for Overlæge (Kirurgisk afdeling)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Rigshospitalet: Kobenhavn, DK

2007 to 2007 | 1. reservelæge (Brystkirurgisk klinik)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Roskilde Sygehus: Roskilde, Sjaelland, DK

2005 to 2007 | 1. reservelæge (Kirurgisk afdeling)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Region Hovedstaden: Hillerod, DK

2001 to 2003 | Kursusstilling i Kirurgi
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Herlev Hospital: Herlev, DK

2001 to 2001 (Kirurgisk Gastroenterologisk afdeling)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Gentofte Hospital: Hellerup, DK

2000 to 2000 | Introduktionsstilling (Ortopædkirurgisk afdeling)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Bispebjerg Hospital: Kobenhavn, DK

1998 to 1999 | Introduktionsstilling (Kirurgisk gastroenterologisk afdeling)
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Roskilde Sygehus: Roskilde, Sjaelland, DK

1995 to 1998 | Turnus
Employment
Source: Self-asserted source
Tove Filtenborg Tvedskov

Education and qualifications (6)

University of Copenhagen: Copenhagen, DK

2017 to present | Dr. med. (faculty of life sciences)
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

Rigshospitalet: Kobenhavn, DK

2013-12-05 to present | Certified Breast Surgeon (Department of Breast Surgery)
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

University of Copenhagen, Faculty of Health Sciences: Copenhagen, DK

2012-05 to present | PhD
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

Roskilde Sygehus: Roskilde, Sjaelland, DK

2007-01-01 to present | Specialit in General Surgery
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

University of Aarhus: Aarhus, DK

1995-06 to present | Cand. Med
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

Århus Universitet: Århus, DK

1984 | Diplomstudie (Det Sundhedsvidenskabelige fakultet)
Education
Source: Self-asserted source
Tove Filtenborg Tvedskov

Professional activities (1)

Danish Breast Cancer Cooperative Group: Copenhagen, DK

Membership
Source: Self-asserted source
Tove Filtenborg Tvedskov

Funding (20)

Onkologiske events efter subcutan mastektomi med eller uden bevarelse af papil-areola kompleks

2025-01 to 2027 | Grant
Danish Cancer Society (Copenhagen, DK)
GRANT_NUMBER:

R374-A22533

Source: Self-asserted source
Tove Filtenborg Tvedskov

Oncologic Events After Subcutaneous Mastectomy With Or Without Conservation Of The Nipple-areola Complex

2024 to 2025 | Grant
ACROBATIC -Dansk forskningscenter for Kræftkirurgi (aarhus, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Targetteret aksildissektion ved brystkræft efter neoadjuverende kemoterapi

2022 to 2024 | Grant
Danish Cancer Society (Copenhagen, DK)
GRANT_NUMBER:

R325-A18625-Rp23054
Source: Self-asserted source
Tove Filtenborg Tvedskov

Skræddersyet kirurgisk behandling af aksillen hos brystkræftpatienter

2015 to 2016 | Grant
Kræftens Bekæmpelse (Copenhagen, DK)
GRANT_NUMBER:

R130-A8152-15-S38
Source: Self-asserted source
Tove Filtenborg Tvedskov

SENOMAC studiet

2015 to 2015 | Grant
Landsforeningen mod Brystkræft (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

The evolution of the sentinel node procedure in the treatment of breast cancer

2014 to 2014 | Grant
Rigshospitalets forskningspuljer (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Kirurgisk behandling af brystkræftpatienter med mikrometastaser eller isolerede tumorceller i sentinel node

2012 to 2016 | Grant
Overlæge Dr med edgar Schnohr og hustru Gilberte Schnohrs fond (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Prognostic significance of axillary lymph node dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: A Nationwide study.

2012 to 2012 | Grant
Harboefonden (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stadieinddeling af kvinder med mammacancer

2012 to 2012 | Contract
IMK almene Fond (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Evaluating TIMP-1, Ki67 and HER2 as markers for non-sentinel lymph node metastases in breast cancer patients with micrometastases in the sentinel lymph nodes: A case-control study.

2011 to 2011 | Grant
Rigshospitalets fond til støtte af onkologiske formål (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Evaluating TIMP-1, Ki67 and HER2 as markers for non-sentinel lymph node metastases in breast cancer patients with micrometastases in the sentinel lymph nodes: A case-control study.

2011 to 2011 | Grant
Novartis oncology (Copenhagen, DK)
GRANT_NUMBER:

1025
Source: Self-asserted source
Tove Filtenborg Tvedskov

High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node.

2011 to 2011 | Grant
Kræftens Bekæmpelse (Copenhagen, DK)
GRANT_NUMBER:

R46-A2423-11-S4
Source: Self-asserted source
Tove Filtenborg Tvedskov

Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer

2010 to 2010 | Grant
Kræftens Bekæmpelse (Copenhagen, DK)
GRANT_NUMBER:

R27-A1368-10-S4
Source: Self-asserted source
Tove Filtenborg Tvedskov

Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer

2010 to 2010 | Salary award
American Association for Cancer Research (PA, PA, US)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stadieinddeling af kvinder med mammacancer

2010 to 2010 | Grant
det medicinske selskab i København (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: A nationwide study.

2010 to 2010 | Grant
Lundbeckfonden (Copenhagen, DK)
GRANT_NUMBER:

R56-A4645
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stadieinddeling af kvinder med mammacancer

2008 to 2011 | Grant
IMK Almene Fond (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stadieinddeling af kvinder med mammacancer

2007 to 2007 | Grant
HovedOrthocenterets forskningsinitiativfond (Copenhagen, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Stadieinddeling af kvinder med mammacancer

2007 to 2007 | Grant
Dansk Kræftforsknings Fond (Copenhagen, DK)
GRANT_NUMBER:

15-07(310367-1816)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Det fibrinolytiske enzymsystem under eksperimentelt

1993 to 1993 | Grant
Århus Universitets Forskningsinitiativfond (Århus, DK)
Source: Self-asserted source
Tove Filtenborg Tvedskov

Peer review (9 reviews for 7 publications/grants)

Review activity for Breast cancer research and treatment. (3)
Review activity for Breast cancer research and treatment. (1)
Review activity for British journal of cancer. (1)
Review activity for British journal of surgery (1)
Review activity for European journal of surgical oncology. (1)
Review activity for Histology and histopathology. (1)
Review activity for Radiotherapy and oncology. (1)
How many people are using ORCID?